五种人新型冠状病毒研究进展(5)
[25] Ying T， Du L， Ju TW， et al. Exceptionally potent neutralization of Middle East respiratory syndrome corona virus by human monoclonal antibodies[J]. J Virol， 2014， 88(14)： 7796-7805.
[26] Chen Z， Bao L， Chen C， et al. Human neutralizing monoclonal antibody inhibition of Middle East respiratory syndrome coronavirus replication in the common marmoset[J]. J Infect Dis， 2017， 215(12)： 1807-1815.
[27] Xu X， Chen P， Wang J， et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J]. SCI China Life Sci， 2020， 63(3)： 457-460.
[28] Zhu N， Zhang D， Wang W， et al. A novel coronavirus from patients with pneumonia in China， 2019[J]. N Engl J Med， 2020， 382(8)： 727-733.
[29] Wu Z， McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China[J]. JAMA， 2020 Feb 24. doi： 10.1001/ jama.2020.2648.
[30] Holshue ML， DeBolt C， Lindquist S， et al. First case of 2019 novel coronavirus in the United States[J]. N Engl J Med， 2020， 382(10)： 929-936., 百拇医药(陈荔萍 周峰)
[26] Chen Z， Bao L， Chen C， et al. Human neutralizing monoclonal antibody inhibition of Middle East respiratory syndrome coronavirus replication in the common marmoset[J]. J Infect Dis， 2017， 215(12)： 1807-1815.
[27] Xu X， Chen P， Wang J， et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J]. SCI China Life Sci， 2020， 63(3)： 457-460.
[28] Zhu N， Zhang D， Wang W， et al. A novel coronavirus from patients with pneumonia in China， 2019[J]. N Engl J Med， 2020， 382(8)： 727-733.
[29] Wu Z， McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China[J]. JAMA， 2020 Feb 24. doi： 10.1001/ jama.2020.2648.
[30] Holshue ML， DeBolt C， Lindquist S， et al. First case of 2019 novel coronavirus in the United States[J]. N Engl J Med， 2020， 382(10)： 929-936., 百拇医药(陈荔萍 周峰)